Yao Jiang

I graduated from Peking University with a B.Sc. degree in Pharmaceutical Sciences before moving to the Peking Union Medical College, Chinese Academy of Medical Sciences to carry on my PhD. My PhD project was focused on targeting drug delivery system construction for cancer therapy where I found a novel peptide for targeting non-small cell lung cancer. After my PhD, I joined the University of Birmingham as a research fellow and start working on a project to investigate new treatments for cancer by drug redeployment research to provide affordable therapies that can be exploited by all including the worlds poorer nations. Our finding suggested a triple-drug combination could form an effective and non-toxic treatment for a range of aggressive blood cancers. This study has led to a clinical trial in 2021 (NCT04997811).

I joined the University of Oxford in 2022 in NDCLS before moving to NDORMS in 2024. My currently research focus on knee arthrofibrosis. The aim of this project is to dissect the cellular & molecular mechanisms underpinning resolving and persistent forms of arthrofibrosis.

OTHER ACTIVITIES

GUEST EDITOR

Frontiers in Molecular Biosciences

Pharmaceutics

PEER REVIEWER

International Journal of Molecular Sciences

Molecular pharmaceutics